Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy.

Jabbour E, Garcia-Manero G, Batty N, Shan J, O'Brien S, Cortes J, Ravandi F, Issa JP, Kantarjian H.

Cancer. 2010 Aug 15;116(16):3830-4. doi: 10.1002/cncr.25247.

2.

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.

Edlin R, Connock M, Tubeuf S, Round J, Fry-Smith A, Hyde C, Greenheld W.

Health Technol Assess. 2010 May;14 Suppl 1:69-74. doi: 10.3310/hta14Suppl1/10. Review.

PMID:
20507806
3.

Comparison between decitabine and azacitidine for the treatment of myelodysplastic syndrome: a meta-analysis with 1,392 participants.

Xie M, Jiang Q, Xie Y.

Clin Lymphoma Myeloma Leuk. 2015 Jan;15(1):22-8. doi: 10.1016/j.clml.2014.04.010. Epub 2014 Jun 12. Review.

PMID:
25042977
4.

Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update.

Joeckel TE, Lübbert M.

Semin Hematol. 2012 Oct;49(4):330-41. doi: 10.1053/j.seminhematol.2012.08.001. Review.

PMID:
23079063
5.

The euphoria of hypomethylating agents in MDS and AML: is it justified?

Sekeres MA.

Best Pract Res Clin Haematol. 2013 Sep;26(3):275-8. doi: 10.1016/j.beha.2013.10.001. Epub 2013 Oct 15. Review.

PMID:
24309530
6.

Decitabine in the treatment of myelodysplastic syndromes.

Santos FP, Kantarjian H, Garcia-Manero G, Issa JP, Ravandi F.

Expert Rev Anticancer Ther. 2010 Jan;10(1):9-22. doi: 10.1586/era.09.164. Review.

PMID:
20014881
7.

Methylation inhibitor therapy in the treatment of myelodysplastic syndrome.

Silverman LR, Mufti GJ.

Nat Clin Pract Oncol. 2005 Dec;2 Suppl 1:S12-23. Review.

PMID:
16341236
8.

Azacitidine for the treatment of myelodysplastic syndrome.

Cataldo VD, Cortes J, Quintás-Cardama A.

Expert Rev Anticancer Ther. 2009 Jul;9(7):875-84. doi: 10.1586/era.09.61. Review.

PMID:
19589026
9.

Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia.

Estey EH.

Leukemia. 2013 Sep;27(9):1803-12. doi: 10.1038/leu.2013.173. Epub 2013 Jun 12. Review.

PMID:
23757301
10.

Review of azacitidine trials in Intermediate-2-and High-risk myelodysplastic syndromes.

Fenaux P, Ades L.

Leuk Res. 2009 Dec;33 Suppl 2:S7-11. doi: 10.1016/S0145-2126(09)70227-9. Review.

PMID:
20004796
11.

Therapy with azanucleosides for myelodysplastic syndromes.

Quintás-Cardama A, Santos FP, Garcia-Manero G.

Nat Rev Clin Oncol. 2010 Aug;7(8):433-44. doi: 10.1038/nrclinonc.2010.87. Epub 2010 Jun 15. Review.

PMID:
20551943
12.

Treatment of advanced myelodysplastic syndrome with demethylating agents: azacitidine.

Adès L, Itzykson R, Fenaux P.

Semin Hematol. 2012 Oct;49(4):323-9. doi: 10.1053/j.seminhematol.2012.09.002. Review.

PMID:
23079062
13.

5-azacytidine and decitabine monotherapies of myelodysplastic disorders.

Kuykendall JR.

Ann Pharmacother. 2005 Oct;39(10):1700-9. Epub 2005 Sep 6. Review.

PMID:
16144884
14.

[Demethylating medication in myelodysplastic syndrome].

Manson ML, Derissen EJ, Wijermans PW, Schellens JH, Beijnen JH.

Ned Tijdschr Geneeskd. 2012;156(4):A3167. Review. Dutch.

PMID:
22278034
15.

[Hypomethylating agents for the treatment of myelodysplastic syndromes].

Itzykson R, Fenaux P.

Bull Cancer. 2011 Aug;98(8):927-34. doi: 10.1684/bdc.2011.1411. Review. French.

16.

Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.

Parikh SA, Tefferi A.

Am J Hematol. 2013 Nov;88(11):967-74. doi: 10.1002/ajh.23574. Review.

17.

Evolving treatment options of myelodysplastic syndromes.

Verbeek W, Ganser A.

Ann Hematol. 2001 Sep;80(9):499-509. Review.

PMID:
11669297
18.

The role of hypomethylating agents in myelodysplastic syndrome: changing the management paradigm.

Merkel DG, Nagler A.

Expert Rev Hematol. 2013 Dec;6(6):665-76. doi: 10.1586/17474086.2013.854699. Epub 2013 Nov 6. Review.

PMID:
24191866

Supplemental Content

Support Center